Los Angeles Capital Management LLC Atreca, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	BUY	$7.82 - $13.8 $96,068 - $169,533	12,285 Added 43.79%	40,339 $344,000
Q1 2021 May 05, 2021	BUY	$13.0 - $19.34 $23,283 - $34,637	1,791 Added 6.82%	28,054 $430,000
Q4 2020 Feb 04, 2021	BUY	$13.03 - $17.09 $78,596 - $103,086	6,032 Added 29.82%	26,263 $424,000
Q3 2020 Nov 02, 2020	BUY	$12.67 - $23.19 $10,642 - $19,479	840 Added 4.33%	20,231 $283,000
Q2 2020 Aug 05, 2020	BUY	$12.52 - $23.45 $242,775 - $454,718	19,391 New	19,391 $412,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.